1. Home
  2. ACHV vs CHCI Comparison

ACHV vs CHCI Comparison

Compare ACHV & CHCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHV
  • CHCI
  • Stock Information
  • Founded
  • ACHV N/A
  • CHCI 1985
  • Country
  • ACHV United States
  • CHCI United States
  • Employees
  • ACHV N/A
  • CHCI N/A
  • Industry
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • CHCI Building operators
  • Sector
  • ACHV Health Care
  • CHCI Real Estate
  • Exchange
  • ACHV Nasdaq
  • CHCI Nasdaq
  • Market Cap
  • ACHV 167.6M
  • CHCI 186.2M
  • IPO Year
  • ACHV N/A
  • CHCI 2004
  • Fundamental
  • Price
  • ACHV $3.17
  • CHCI $14.13
  • Analyst Decision
  • ACHV Strong Buy
  • CHCI
  • Analyst Count
  • ACHV 1
  • CHCI 0
  • Target Price
  • ACHV $12.00
  • CHCI N/A
  • AVG Volume (30 Days)
  • ACHV 727.0K
  • CHCI 24.4K
  • Earning Date
  • ACHV 11-06-2025
  • CHCI 11-06-2025
  • Dividend Yield
  • ACHV N/A
  • CHCI N/A
  • EPS Growth
  • ACHV N/A
  • CHCI 83.14
  • EPS
  • ACHV N/A
  • CHCI 1.51
  • Revenue
  • ACHV N/A
  • CHCI $55,514,000.00
  • Revenue This Year
  • ACHV N/A
  • CHCI N/A
  • Revenue Next Year
  • ACHV N/A
  • CHCI N/A
  • P/E Ratio
  • ACHV N/A
  • CHCI $9.08
  • Revenue Growth
  • ACHV N/A
  • CHCI 18.44
  • 52 Week Low
  • ACHV $1.84
  • CHCI $6.31
  • 52 Week High
  • ACHV $5.31
  • CHCI $18.99
  • Technical
  • Relative Strength Index (RSI)
  • ACHV 51.96
  • CHCI 45.14
  • Support Level
  • ACHV $3.07
  • CHCI $13.36
  • Resistance Level
  • ACHV $3.48
  • CHCI $14.15
  • Average True Range (ATR)
  • ACHV 0.15
  • CHCI 0.89
  • MACD
  • ACHV -0.01
  • CHCI -0.13
  • Stochastic Oscillator
  • ACHV 34.85
  • CHCI 28.39

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About CHCI Comstock Holding Companies Inc.

Comstock Holding Co Inc is a developer and manager of mixed-use and transit-oriented properties with operations that are majorly focused on the Washington, D.C. metropolitan area. It provides a range of services such as asset management, property management, development and construction management, and other real estate-related services to its asset-owning clients, composed predominantly of institutional real estate investors, high net worth family offices, financial institutions, and governmental bodies seeking to enhance their surrounding communities by developing real estate through public-private partnerships.

Share on Social Networks: